Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Molecular Templates, Inc. (NASDAQ: MTEM).

Full DD Report for MTEM

You must become a subscriber to view this report.


Recent News from (NASDAQ: MTEM)

Today's Research Reports on Stocks to Watch: Molecular Templates and Altimmune
NEW YORK, NY / ACCESSWIRE / September 20, 2018 / Despite any news yesterday, shares of Altimmune were soaring and closed up roughly 285%. It was in early September that the company announced positive mid-stage data on its intranasal egg-free flu vaccine candidate NasoVax . Shares of Molecul...
Source: ACCESSWIRE IA
Date: September, 20 2018 08:00
Premarket Gainers as of 9:05 am (09/19/2018)
MTEM   +51%  on Takeda development deal . More news on: Molecular Templates, Inc., Tilray, Inc., Command Security Corporation, Stocks on the move, Top stock market news, , Read more ...
Source: SeekingAlpha
Date: September, 19 2018 09:23
Molecular Templates up 41% premarket on Takeda development deal
Thinly traded micro cap Molecular Templates (NASDAQ: MTEM ) is up  41%  premarket on increased volume in response to its deal with Takeda Pharmaceutical ( OTCPK:TKPYY )( OTCPK:TKPHF ) for the joint development of CD38-targeted engineered toxin antibodies (ETBs) for the treatment ...
Source: SeekingAlpha
Date: September, 19 2018 08:42
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
The Agreement Will Support the Development of a Potential New Treatment Option for Multiple Myeloma AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the...
Source: GlobeNewswire
Date: September, 19 2018 08:00
Analysis: Positioning to Benefit within Quanex Building Products, Molecular Templates, Atara Biotherapeutics, Forward Industries, Apollo Endosurgery, and Myomo - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK,, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quanex Building Products Corporation (NYSE:NX), Molecular Templates Inc....
Source: GlobeNewswire
Date: August, 16 2018 07:40
Molecular Templates misses by $0.11
Molecular Templates (NASDAQ: MTEM ): Q2 EPS of -$0.36 misses by $0.11 . Revenue of $1.37M (+3325.0% Y/Y) Press Release More news on: Molecular Templates, Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: August, 09 2018 17:00
Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results
AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bo...
Source: GlobeNewswire
Date: August, 09 2018 16:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-144.124.174.354.1041,246

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1113,35551,24226.0626Cover
2018-12-103,88011,65633.2876Cover
2018-12-076,53522,79828.6648Cover
2018-12-065,15219,82525.9874Cover
2018-12-044,06319,90420.4130Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MTEM.


About Molecular Templates, Inc. (NASDAQ: MTEM)

Logo for Molecular Templates, Inc. (NASDAQ: MTEM)

Not available

 

Contact Information

 

 

Current Management

  • Harold E Selick / CEO

Current Share Structure

  • Market Cap: $198,607,511 - 05/17/2018
  • Issue and Outstanding: 27,058,244 - 03/21/2018

 


Recent Filings from (NASDAQ: MTEM)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 09 2018
Post-effective amendment to an S-8 filing
Filing Type: S-8 POSFiling Source: edgar
Filing Date: August, 03 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: July, 13 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: July, 13 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: July, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 22 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: June, 22 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: June, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 21 2018

 

 


Daily Technical Chart for (NASDAQ: MTEM)

Daily Technical Chart for (NASDAQ: MTEM)


Stay tuned for daily updates and more on (NASDAQ: MTEM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: MTEM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MTEM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MTEM and does not buy, sell, or trade any shares of MTEM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/